Sign in
8-K

Current Report

CRISPR Therapeutics AG Filed Acc 0000950170-23-009861

Material agreement · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading crsp-20230323.htm…